Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice

L. G. E. M. Razenberg*, Y. R. B. M. van Gestel, Ignace H. J. T. de Hingh, Olaf J. L. Loosveld, G. Vreugdenhil, Laurens V. Beerepoot, G.J. Creemers, Valery E. P. P. Lemmens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number110
Pages (from-to)1-9
Number of pages9
JournalBMC Cancer
Volume16
DOIs
Publication statusPublished - 16 Feb 2016

Keywords

  • Colorectal cancer
  • Metachronous metastases
  • Palliative
  • Chemotherapy
  • Targeted therapy
  • Bevacizumab

Cite this